|
|
|
|
|
by daveguy
3440 days ago
|
|
Obviously it depends on how strong the effect is. The point is you identify the effect and the power. If you get to 1600 people and you are seeing a > 10% effect then sure -- you can stop. As long as you have sufficient power. The point is you must know what the statistical power is, and know where your break points are. You absolutely can not stop just at seeing a 10% effect -- which could happen if you happen to get one in the first 10 samples. That is not dogmatic, it is good statistics. Take your example. 100 patients, all dead or 100 patients all alive -- you have demonstrated an infinite effect (edit: ok no need to be hyperbolic, 99+% effect), and probably have covered statistical rigor. If your drug is that effective you are probably criminally liable a lot sooner than 100 dead patients. Unfortunately actual medical (and A/B) studies do not mimic make believe scenarios. |
|